OSTEO PRO
Advanced Intra-Articular Therapy for Knee Osteoarthritis
Multi-modal injectable solution designed to restore joint function, reduce inflammation, and support cartilage microenvironment optimization in a single injection.
Redefining Intra-Articular Therapy
Osteo Pro is an advanced intra-articular injectable formulation, engineered in Germany, developed for the management of osteoarthritis through a multi-modal therapeutic approach.
Unlike conventional viscosupplementation that focuses primarily on lubrication, Osteo Pro combines mechanical support with biologically active modulation, targeting the full complexity of osteoarthritis ,including inflammation, cellular dysfunction, and loss of joint homeostasis. Current conservative management of osteoarthritis is summarised in the NICE osteoarthritis guideline (NG226).
Clinical Indication in Knee Osteoarthritis
Osteo Pro is indicated for the management of symptomatic mild to moderate knee osteoarthritis (Kellgren–Lawrence grade I–III), particularly in patients with inadequate response to conservative therapy. Contact our medical team for application protocols and product information.
Why Osteo Pro
- Multi-modal therapeutic approach
- Single-injection convenience
- Combined mechanical + biological action
- Designed for real clinical outcomes
CROSS-LINKED
Long-Lasting Joint Support
Cross-linked Hyaluronic Acid (90 mg) provides sustained viscoelastic supplementation by restoring synovial fluid properties, improving load distribution, and enhancing shock absorption.
Its resistance to enzymatic degradation allows extended intra-articular persistence, contributing to long-term pain relief and functional improvement.
DUAL MOLECULAR
Precision Lubrication + Cellular Signaling
The combination of High and Low Molecular Weight HA (90 mg) delivers both mechanical and biological.
benefits.
- HMW HA: restores lubrication and mimics natural synovial fluid
- LMW HA: supports cellular signaling via CD44 pathways
Together, they contribute to joint homeostasis and synovial environment optimization..
PDRN
Targeted Anti-Inflammatory Modulation
The combination of High and Low Molecular Weight HA (90 mg) delivers both mechanical and biological.
It supports tissue repair through stimulation of fibroblast and chondrocyte activity and promotes angiogenesis offering a non-steroidal pathway for inflammation control.
PLACENTA EXTRACT
Microenvironment Regeneration Support
Human Placenta Extract provides bioactive compounds including growth factors, peptides, and nucleic acids that support cellular metabolism and extracellular matrix dynamics.
